CTRI/2023/12/060545尚未招募4 期
Molecular Mechanisms of Immunomodulation Imparted by Mycobacterium indicus pranii (MIP) vaccine against multibacillary leprosy - M2I2MIP
eprosy Research Initiative (LRI), Netherlands0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. New leprosy case (before the start of MDT)
- •2. Age above 15 years, and with a bacteriological index (BI) of >2
- •3. The patients meeting the above criteria and also willing to be tested for lepromin reactivity will be considered for inclusion. Lepromin reactivity will be tested as per the standard method
排除标准
- •1. Age below 15 years
- •2. Unable or unwilling to provide written informed consent
- •3. Pregnancy and Lactation
- •4. Other dermatological or mycobacterial diseases
- •5. Patients with co-morbidities like Diabetes
- •6. HIV, primary or secondary immune suppression
研究者
相似试验
尚未招募
1 期
Study for Immune Molecular Mechanism in the Treatment of Sequelae of Pelvic Inflammatory Disease of Accumulated Damp Heat with Penyanxiao in Combination with Pelvic PerfusioITMCTR2000002965Xianyang Central Hospital
已完成
4 期
Characterization of the immuno-modulatory effects of Tecfidera in multiple sclerosis patients: exploration of drug mechanism and methodological feasibility.Reduced lymphocyte count. Reduced white bloodcell count.10047954NL-OMON42490Centre for Human Drug Research16
尚未招募
2 期
Immuno -Modulatory Potential of AyurRaksha Kit and Its Preventive Impact on COVID 19 In Delhi PoliceCTRI/2021/08/035745Ministry of AYUSH
已完成
Unknown
An Exploratory Study of the Immunomodulatory Function of Test Supplements in Healthy Adults - A Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Comparative TrialJPRN-UMIN000051731IMEQRD Co., Ltd60
进行中（未招募）
1 期
Explorative analysis of the immunmodulatory capacities of apathogenic Escherichia coli Nissle 1917 in patients with rhinoconjunctivitis due to grass pollen allergy.EUCTR2008-006335-12-DEProf. Dr. med. Margitta Worm34